New digital pathology player enters market

Brian Dunham | | Health Imaging | Enterprise Imaging
DigiPath entered the digital pathology market July 7, claiming to provide an affordable alternative to current pathology technologies.

In addition to digital pathology technologies, the company also provides advisory services, including: marketing, product development, outreach and sales, operations, customer service as well as regulatory and financial services.

 

Brian Dunham

Related Content

Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.